Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Plasma cell 1

Conditions

Multiple Myeloma 251Neoplasms, Plasma Cell 91Lymphoma, Non-Hodgkin 33Hodgkin Disease 33Leukemia, Lymphocytic, Chronic, B-Cell 30Lymphoma 29Leukemia 29Immunoglobulin Light-chain Amyloidosis 29Myelodysplastic Syndromes 27Precursor Cell Lymphoblastic Leukemia-Lymphoma 26Leukemia, Myeloid, Acute 25Lymphoma, Mantle-Cell 20Lymphoma, Follicular 20Myeloproliferative Disorders 19Lymphoma, Large B-Cell, Diffuse 19Lymphoma, B-Cell, Marginal Zone 19Recurrence 17Lymphoma, Large-Cell, Immunoblastic 17Burkitt Lymphoma 17Primary Myelofibrosis 14Congenital Abnormalities 14Anemia, Aplastic 13Waldenstrom Macroglobulinemia 12Leukemia, Myeloid, Chronic-Phase 12Leukemia, Myeloid, Accelerated Phase 12Leukemia, Myelomonocytic, Chronic 11Hematologic Neoplasms 11Graft vs Host Disease 11Dendritic Cell Sarcoma, Interdigitating 10Lymphoma, T-Cell, Cutaneous 9

Interventions

Dexamethasone 12Bortezomib 9Lenalidomide 6Cyclophosphamide 5isatuximab 3fludarabine 3daratumumab 3Granulocyte Colony-Stimulating Factor 3pomalidomide 2filanesib 2dacetuzumab 2Tacrolimus 2Steroids 2Injections, Subcutaneous 2Filgrastim 2Clinical Protocols 2Calcium Dobesilate 2Alemtuzumab 2plerixafor 1nirogacestat 1fludarabine phosphate 1ficlatuzumab 1birtamimab 1Zoledronic Acid 1Whole-Body Irradiation 1Vorinostat 1Tissue Banks 1Thalidomide 1Stem Cell Transplantation 1Ranitidine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Paraproteinemias × Melphalan × Plasma cell × Clear all
NCT01548573 2017-06-14

Tandem Auto Transplantation in Myeloma Patients With <12 Months of Prior Treatment

University of Iowa

Phase 2 Terminated
19 enrolled 7 charts
Plasma cell

Amyloidosis, Endocrine System Diseases, Multiple Myeloma, Paraproteinemias, Polyneuropathies

Data powered by HemOnc (CC BY 4.0) Colophon âš¡